Creative Medical Technology Holdings Inc (CELZ) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and no strong trading signals. It is better to hold off on investing in this stock at this time.
The MACD is positive and expanding, indicating a potential bullish trend. However, the RSI is in the neutral zone at 72.853, and moving averages are converging, suggesting no clear trend. Key resistance levels are at 2.375 and 2.488, while support levels are at 2.008 and 1.895.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The stock has a high probability of declining (-1.45%) in the next week, and financial performance remains weak with negative EPS and net income.
In Q4 2025, revenue remained flat YoY at 3000. Net income improved slightly by 1.81% YoY but remains negative at -1,887,674. EPS dropped significantly by -35.78% YoY to -0.7. Gross margin improved by 38.89% YoY but remains deeply negative at -964.77.
No analyst ratings or price target changes available.